These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6386695)

  • 21. Monoclonal antibodies against the capsular K antigen of Escherichia coli (O9:K30(A):H12): characterisation and use in analysis of K antigen organisation on the cell surface.
    Homonylo MK; Wilmot SJ; Lam JS; MacDonald LA; Whitfield C
    Can J Microbiol; 1988 Oct; 34(10):1159-65. PubMed ID: 2461792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective capacity of antibodies to outer-membrane components of Escherichia coli in a systemic mouse peritonitis model.
    Vuopio-Varkila J; Karvonen M; Saxén H
    J Med Microbiol; 1988 Feb; 25(2):77-84. PubMed ID: 2448461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
    Colino J; Outschoorn I
    Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of protection against ascending Escherichia coli pyelonephritis in diabetic rats following immunization with purified lipopolysaccharide.
    Bryan LE; Schollaardt T; Pak CY; Kim CJ; Yoon JW
    Can J Microbiol; 1986 Dec; 32(12):967-9. PubMed ID: 3545411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV; Bradley C; Brady W; Donaldson K; Lipsich L; Maloney G; Shuford W; Walls M; Ward P; Wolff E
    J Infect Dis; 1991 Feb; 163(2):346-54. PubMed ID: 1988519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Haemophilus influenzae type b idiotype 1 on naturally acquired antibodies.
    Ulanova M; Hahn-Zoric M; Lau YL; Lucas A; Hanson LA
    Clin Exp Immunol; 1996 Sep; 105(3):422-8. PubMed ID: 8809129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel cell surface polysaccharide in Pseudomonas putida WCS358, which shares characteristics with Escherichia coli K antigens, is not involved in root colonization.
    de Weger LA; Bloemberg GV; van Wezel T; van Raamsdonk M; Glandorf DC; van Vuurde J; Jann K; Lugtenberg BJ
    J Bacteriol; 1996 Apr; 178(7):1955-61. PubMed ID: 8606170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.
    Moreno C; Hewitt J; Hastings K; Brown D
    J Gen Microbiol; 1983 Aug; 129(8):2451-6. PubMed ID: 6415230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal concentration of human IgM and IgG antibodies necessary to protect mice from challenges with live O6 Escherichia coli.
    Massironi SM; Arslanian C; Carneiro-Sampaio MM; Pontes GN
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):193-201. PubMed ID: 22077222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immune response to bacterial dextrans. V. A "dominant" idiotype in IgCHb mice.
    Lundkvist I; Ivars F; Holmberg D; Coutinho A
    J Immunol; 1987 Jun; 138(12):4395-401. PubMed ID: 2438342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues.
    Finne J; Bitter-Suermann D; Goridis C; Finne U
    J Immunol; 1987 Jun; 138(12):4402-7. PubMed ID: 3108388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
    Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
    J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral vaccination of mice and piglets with F4+ Escherichia coli suppresses the enteric anti-F4 response upon oral infection.
    Bianchi AT; Scholten JW; van Zijderveld AM; van Zijderveld FG; Bokhout BA
    Vaccine; 1996 Feb; 14(3):199-206. PubMed ID: 8920700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.
    Schiff DE; Wass CA; Cryz SJ; Cross AS; Kim KS
    Infect Immun; 1993 Mar; 61(3):975-80. PubMed ID: 7679376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.
    Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H
    J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA.
    Kabat EA; Nickerson KG; Liao J; Grossbard L; Osserman EF; Glickman E; Chess L; Robbins JB; Schneerson R; Yang YH
    J Exp Med; 1986 Aug; 164(2):642-54. PubMed ID: 3088209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation studies on Escherichia coli capsular polysaccharides by bacteriophages.
    Nimmich W
    FEMS Microbiol Lett; 1997 Aug; 153(1):105-10. PubMed ID: 9252579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.
    Cerca N; Maira-Litrán T; Jefferson KK; Grout M; Goldmann DA; Pier GB
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7528-33. PubMed ID: 17446272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.
    Cross AS; Zollinger W; Mandrell R; Gemski P; Sadoff J
    J Infect Dis; 1983 Jan; 147(1):68-76. PubMed ID: 6401788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.